AviaraDx’s diagnostic tests can be used in the molecular classification of cancers and to assist oncologists in making therapeutic decisions.
Aviara CancerType ID provides improved cancer classification, especially for patients diagnosed with metastatic cancer where the origin is uncertain or unknown.
Aviara Breast Cancer Index offers a combined assessment of two Aviara markers (H/l and MGI) for risk prognosis and treatment response prediction for chemo- and hormonal therapy.
Online:
www.biomerieux.com.au
Phone: 1800 333 421
Phone: 1800 333 421
Related Products
Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry
The range provides users with more options when designing spectral flow cytometry panels,...
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
Immundiagnostik ID-Vit MTP assays
Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...
